Structural Genomics Consortium (SGC)
@thesgc.bsky.social
220 followers 19 following 25 posts
A public-private partnership seeking to accelerate drug discovery through pre-competitive, open access research. More about us at thesgc.org
Posts Media Videos Starter Packs
Reposted by Structural Genomics Consortium (SGC)
mattschap.bsky.social
CACHE 7 is launched with support from the @gatesfoundation.bsky.social and unpublished data from Damian Young at @bcmhouston.bsky.social, Tim Willson @thesgc.bsky.social and Neelagandan Kamaria InSTEM. Design selective PGK2 inhibitors. We'll test them experimentally.
bit.ly/4lnVYOs
thesgc.bsky.social
Check how we are going to transform early-stage hit-finding into a data-driven, computational process driven by open science.

www.nature.com/articles/s41...
Reposted by Structural Genomics Consortium (SGC)
mattschap.bsky.social
CACHE4 results are out! All previously known CBLCB ligands shared the same scaffold. Congrats to Keunwan Park who successfully designed a chemically novel series, to the experimental team at @thesgc.bsky.social and thanks to @conscience-network.bsky.social for greasing the wheels! bit.ly/4mYNe3r
Reposted by Structural Genomics Consortium (SGC)
gsbardella.bsky.social
The last talk of the day at the 11th Novalix Conference “Biophysics in Drug Discovery” was the terrific keynote lecture by Stefan Knapp on "Comprehensive Characterization of Chemical Tools and New Modalities such as PROTACs".
@thesgc.bsky.social
Reposted by Structural Genomics Consortium (SGC)
mattschap.bsky.social
@thesgc.bsky.social is generating large/open screening data and inviting data scientists to train their ML models via DREAM challenges:
1- train your model on DEL data
2- retrospectively predict 138 ASMS true positives
3- predict new hits. We will test them and publish together.
bit.ly/3YXVKoT
First DREAM Target 2035 Drug Discovery Challenge
'First DREAM Target 2035 Drug Discovery Challenge' (Synapse ID: syn65660836) is a project on Synapse. Synapse is a platform for supporting scientific collaborations centered around shared biomedic...
bit.ly
thesgc.bsky.social
Advancing AI-driven drug discovery begins with open, high-quality data. A great editorial with the authors highlighting how openly accessible datasets have historically accelerated scientific breakthroughs and spotlighting our open data platform: aircheck.ai

More: www.science.org/doi/10.1126/...
AI drug development’s data problem
The future of drug discovery may be artificial intelligence (AI), but its present is not. AI is in its infancy in the field. To help AI mature, developers need nonproprietary, open, large, high-qualit...
www.science.org
Reposted by Structural Genomics Consortium (SGC)
aledmedwards.bsky.social
Advancing ML and drug discovery. @thesgc.bsky.social is now starting to generate protein-ligand data at scale. We’re partnering with CASP, CACHE and DREAM/Sage to run challenges on these data, and help critically assess computational hit-finding methods. Participate!
www.synapse.org/Synapse:syn6...
First DREAM Target 2035 Drug Discovery Challenge
'First DREAM Target 2035 Drug Discovery Challenge' (Synapse ID: syn65660836) is a project on Synapse. Synapse is a platform for supporting scientific collaborations centered around shared biomedic...
www.synapse.org
Reposted by Structural Genomics Consortium (SGC)
thesgc.bsky.social
In the past two decades, we've distributed over 5,200 plasmids through Addgene, supporting research at 1,084 organizations in 55 countries.
thesgc.bsky.social
Want to learn more?

🎙️ The Target 2035 podcast breaks down CACHE challenges: open.spotify.com/episode/0bLH...

🎤 The Conscience Symposium on Open Drug Discovery
will feature CACHE participants: conscience.ca/symposium2025

🔗 Learn more about CACHE Challenges: conscience.ca/cache-challe...
Episode 5: CACHE – Benchmarking Computational Hit Discovery
Target 2035 Podcast series · Episode
open.spotify.com
thesgc.bsky.social
🚀 100 scientists. 31 countries. And we’re just getting started.

#MAINFRAME is uniting global experts to drive AI-powered hit finding. ML models trained on real experimental data. Predictive tools tested in the lab.

🔗 Now is the time to join: aircheck.ai/mainframe
Reposted by Structural Genomics Consortium (SGC)
proteocure.bsky.social
Join us for the next ProteoCure Webinar on March 20th at 1PM (CET)! Nicola Burgess-Brown from @thesgc.bsky.social will discuss how you can contribute your proteins for screening and obtain protein ligands! Learn more here: proteocure.eu/proteocure-w.... Don't miss out!
Nicola Burgess-Brown Webinar Announcement
Reposted by Structural Genomics Consortium (SGC)
mattschap.bsky.social
The CACHE #2 preprint is now online: bit.ly/3DyCmHN Active learning and fragment growing delivered confirmed hits. A citizen scientist using the Fold-it gaming interface designed the top compound! Kudos to Sasha and Madhushika @thesgc.bsky.social at the bench. @conscience-network.bsky.social
Reposted by Structural Genomics Consortium (SGC)
colegroupncl.bsky.social
"CACHE Challenge 2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13" is out now on ChemRxiv: dx.doi.org/10.26434/che...

You can find a discussion of our workflow and designed compound in the preprint (WF1438), which was among 13 compounds confirmed to bind to Nsp13.
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target...
dx.doi.org
Reposted by Structural Genomics Consortium (SGC)
chemicalprobes.org
The Chemical Probes Portal now covers 601 protein targets, expanding resources for chemical biology & drug discovery! 🧪🔬 New high-quality probes target DCTPP1, MASTL, HCN1, plus E3 ligases & PROTACs for protein degradation. Learn more: www.chemicalprobes.org/news/600-tar... #ChemicalProbes
Reposted by Structural Genomics Consortium (SGC)
conscience-network.bsky.social
#RareDiseaseDay tomorrow, we are proud to announce the first three recipients of our Developing Medicines through Open Science (DMOS) program! These projects focus on three rare diseases that currently lack effective treatments. Read the press release here: conscience.ca/news/dmos-pr...
DMOS program funds three projects working towards treatments for rare diseases - Conscience
We are proud to announce the first three recipients of funding via our Developing Medicines through Open Science program. These grantees are working towards treatments and cures for three rare disease...
conscience.ca
thesgc.bsky.social
A new study revealed 4 distinct mechanisms through which small molecules can inhibit helicase activity. Through their analysis, they identified key binding pockets that could be targeted for drug discovery and development for cancer and infectious diseases.

pubs.acs.org/doi/10.1021/...
Structural Chemistry of Helicase Inhibition
Helicases are essential motor enzymes that couple nucleoside-triphosphate hydrolysis with DNA or RNA strand unwinding. Helicases are integral to replication, transcription, splicing, and translation o...
pubs.acs.org
thesgc.bsky.social
The AIRCHECK Workshop isn't just another conference! It is an exclusive opportunity to learn, experiment, and get ahead of the curve in ML/AI-driven hit discovery.

Register now: event.fourwaves.com/aircheckwork...
Aircheck
Aircheck for Artificial Intelligence-Ready CHEmiCal Knowledge bases
aircheck.ai
thesgc.bsky.social
An inspiring story that we are extremely proud to be part of! Kudos to David Drewry and Opher Gileadi who worked along with Paul Workman to identify small molecules that target a historically undruggable transcription factor.

Read their publication: www.nature.com/articles/s41...
thesgc.bsky.social
Can you love computational work and experimental research at the same time? @mattschap.bsky.social and
@rjharding.bsky.social have kicked off the first CrossTALK Bootcamp and they are ready to bring together the next generation of drug discovery experts!

www.thesgc.org/blogs/bridgi...
Bridging the Gap: CrossTALK Bootcamp Unites Computational and Experimental Scientists for Drug Discovery | Structural Genomics Consortium
By Sofia Melliou
www.thesgc.org